2,032
Views
2
CrossRef citations to date
0
Altmetric
Articles

UK Medical Cannabis Registry: A Patient Evaluation

, & ORCID Icon
Pages 170-177 | Received 23 Mar 2022, Accepted 31 Aug 2022, Published online: 10 Feb 2023

References

  • Biggane AM, Olsen M, Williamson PR. PPI in research: a reflection from early stage researchers. Res Involv Engagem. 2019;5(1):9. doi:10.1186/S40900-019-0170-2/PEER-REVIEW.
  • Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9. doi:10.1016/S0140-6736(09)60329-9.
  • Stephens R, Staniszewska S. One small step. Res Involv Engagem. 2015;1:1–3. doi:10.1186/S40900-015-0005-8/METRICS.
  • Ward PR, Thompson J, Barber R, Armitage CJ, Boote JD, Cooper CL, Jones GL. Critical perspectives on “consumer involvement” in health research: epistemological dissonance and the know-do gap. J Sociol. 2010;46:63–82. doi:10.1177/1440783309351771.
  • Greenhalgh T, Hinton L, Finlay T, Macfarlane A, Fahy N, Clyde B, Chant A. Frameworks for supporting ­patient and public involvement in research: systematic review and co‐design pilot. Health Expect. 2019;22(4):785–801. doi:10.1111/hex.12888.
  • Edelman N, Barron D. Evaluation of public involvement in research: time for a major re-think? J Health Serv Res Policy. 2016;21(3):209–11. doi:10.1177/1355819615612510.
  • Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, Brito JP, Boehmer K, Hasan R, Firwana B, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14(1):89. doi:10.1186/1472-6963-14-89/FIGURES/3.
  • Oliver S, Liabo K, Stewart R, Rees R. Public involvement in research: Making sense of the diversity. J Health Serv Res Policy. 2015;20(1):45–51. doi:10.1177/1355819614551848.
  • Banerjee R, Erridge S, Salazar O, Mangal N, Couch D, Pacchetti B, Sodergren MH. Real World Evidence in Medical Cannabis Research. Ther Innov Regul Sci. 2022;56(1):8–14. doi:10.1007/S43441-021-00346-0.
  • Aguilar S, Gutiérrez V, Sánchez L, Nougier M. Medicinal cannabis policies and practices around the world. International Drug Policy Consortium; 2018. https://idpc.net/publications/2018/04/medicinal-cannabis-policies-and-practices-around-the-world. Last Accessed August 1, 2022.
  • Erridge S, Salazar O, Kawka M, Holvey C, Coomber R, Usmani A, Sajad M, Beri S, Hoare J, Khan S, et al. An initial analysis of the UK Medical Cannabis Registry: outcomes analysis of first 129 patients. Neuropsychopharmacol Rep. 2021;41(3):362–70. doi:10.1002/npr2.12183.
  • Case P. The NICE guideline on medicinal Cannabis: keeping Pandora’s box shut tight? Med Law Rev. 2020;28(2):401–11. doi:10.1093/MEDLAW/FWAA002.
  • Harris M, Erridge S, Ergisi M, Nimalan D, Kawka M, Salazar O, Ali R, Loupasaki K, Holvey C, Coomber R, et al. UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions. Expert Rev Clin Pharmacol. 2022;15(4):473–485. doi:10.1080/1751243320222017771.
  • Ergisi M, Erridge S, Harris M, Kawka M, Nimalan D, Salazar O, Loupasaki K, Ali R, Holvey C, Coomber R, et al. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder. Expert Rev Clin Pharmacol. 2022;15(4):487–495. doi:10.1080/1751243320222020640.
  • Nimalan D, Kawka M, Erridge S, Ergisi M, Harris M, Salazar O, Ali R, Loupasaki K, Holvey C, Coomber R, et al. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes. J Cannabis Res. 2022;4(1):3. doi:10.1186/S42238-021-00114-9.
  • Kawka M, Erridge S, Holvey C, Coomber R, Usmani A, Sajad M, Platt MW, Rucker JJ, Sodergren MH. Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom: analysis from the UK Medical Cannabis Registry. J Clin Pharmacol. 2021;61(12):1545–1554. doi:10.1002/jcph.1961.
  • Ergisi M, Erridge S, Harris M, Kawka M, Nimalan D, Salazar O, Loupasaki K, Ali R, Holvey C, Coomber R, et al. An updated analysis of clinical outcome measures across patients from the UK Medical Cannabis Registry. Cannabis Cannabinoid Res. 2022. Epub ahead of print. doi:10.1089/CAN.2021.0145.
  • Khozin S, Coravos A. Decentralized trials in the age of real-world evidence and inclusivity in clinical investigations. Clin Pharmacol Ther. 2019;106(1):25–7. doi:10.1002/CPT.1441.
  • Decentralized Clinical Trials Bring Research to the Participant - CTTI [Internet]. [cited 2022 Feb 3]. Available from: https://ctti-clinicaltrials.org/type/media-coverage/decentralized-clinical-trials-bring-research-to-the-participant/.
  • Nielsen AS, Kidholm K, Kayser L. Patients’ reasons for non-use of digital patient-reported outcome concepts: A scoping review. Health Inform J. 2020;26(4):2811–33. doi:10.1177/1460458220942649.
  • Szyliowicz D, Hilsenrath P. Medical marijuana knowledge and attitudes: a survey of the california pharmacists association. J Prim Care Community Health. 2019;10:2150132719831871. doi:10.1177/2150132719831871.
  • Haroutounian S, Arendt-Nielsen L, Belton J, Blyth FM, Degenhardt L, Di Forti M, Eccleston C, Finn DP, Finnerup NB, Fisher E, et al. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: ­research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. 2021;162(Suppl 1):S117–S124. doi:10.1097/j.pain.0000000000002266.
  • Bonn-Miller MO, Pollack CV, Casarett D, Dart R, Elsohly M, Good L, Guzmán M, Hanuš L, Hill KP, Huestis MA, et al. Priority considerations for medicinal cannabis-related research. Cannabis Cannabinoid Res. 2019;4(3):139–57. doi:10.1089/CAN.2019.0045.